Case James Brett, Jain Shilpi, Suthar Mehul S, Diamond Michael S
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA; email:
Emory Vaccine Center, Emory National Primate Research Center, Atlanta, Georgia, USA.
Annu Rev Immunol. 2025 Apr;43(1):29-55. doi: 10.1146/annurev-immunol-083122-043054. Epub 2024 Dec 20.
The persistence of SARS-CoV-2 infections at a global level reflects the repeated emergence of variant strains encoding unique constellations of mutations. These variants have been generated principally because of a dynamic host immune landscape, the countermeasures deployed to combat disease, and selection for enhanced infection of the upper airway and respiratory transmission. The resulting viral diversity creates a challenge for vaccination efforts to maintain efficacy, especially regarding humoral aspects of protection. Here, we review our understanding of how SARS-CoV-2 has evolved during the pandemic, the immune mechanisms that confer protection, and the impact viral evolution has had on transmissibility and adaptive immunity elicited by natural infection and/or vaccination. Evidence suggests that SARS-CoV-2 evolution initially selected variants with increased transmissibility but currently is driven by immune escape. The virus likely will continue to drift to maintain fitness until countermeasures capable of disrupting transmission cycles become widely available.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染在全球范围内持续存在,这反映了编码独特突变组合的变异株反复出现。这些变异株的产生主要是由于动态变化的宿主免疫环境、为抗击疾病而采取的应对措施,以及对上呼吸道感染增强和呼吸道传播的选择。由此产生的病毒多样性给维持疫苗效力的接种工作带来了挑战,尤其是在保护的体液方面。在此,我们回顾我们对SARS-CoV-2在大流行期间如何进化、赋予保护作用的免疫机制,以及病毒进化对自然感染和/或接种疫苗引发的传播性和适应性免疫的影响的理解。有证据表明,SARS-CoV-2的进化最初选择了传播性增加的变异株,但目前是由免疫逃逸驱动的。在能够破坏传播循环的应对措施广泛可用之前,该病毒可能会继续变异以维持适应性。